Sexually Transmitted Diseases (STD) Diagnostics Market
Segments - by Types (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and Others), Locations of Testing (Laboratory Testing [Commercial/Private labs and Public Health Labs], and Point of Care Testing), Testing Devices (Laboratory Devices [Thermal Cyclers- PCR, Lateral Flow Readers, Flow Cytometers, Differential Light Scattering Machines, Absorbance Microplate Readers—Enzyme-Linked Immunosorbent Assay, and Others] and Point of Care Devices [Phone Chips and Portable/bench top/rapid diagnostic kits]), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global STD diagnostics market size is projected to expand at a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increase in patient awareness such as education campaigns and growing government initiatives. Furthermore, the rising prevalence of sexually transmitted disease (STD) due to growing number of people who have several casual sex partners.
STDs, also known as venereal diseases (VDs), are sexually oriented diseases that are generally transmitted due to having frequent casual sex and sharing of unsterilized drug needles. The disease can be transmitted from mother to baby during birth or breast-feeding, blood transfusions, and sexual contact. Using a variety of tests including blood tests, urine samples, and fluid samples, the detection of STDs is possible even though there are no symptoms. STD is mainly caused by bacteria and this can be treated with antibiotics and antiviral drugs. Absorbance microplate readers, flow cytometers, scattering machines, and immunochromatographic assays are among the instruments used to diagnose the disease.
A major change from conventional laboratory research to rapid point-of-care testing is a key aspect for fueling the market development. Introduction in a series of innovative technologically and new product including diagnostic kits, instruments, and reagents further pushes the market expansion. The increasing prevalence of various infections such as chlamydia, syphilis, gonorrhoea, herpes simplex virus, human immunodeficiency virus, and other infections such as trichomonas vaginitis and vaginitis are expected to drive the market growth. Gongorrhea, chlamydia, and syphilis are bacterial STIs while genital herpes, HIV, genital warts (HPV), and hepatitis are viral STIs. STI-causing microorganisms can be found in the blood, sperm, and vaginal fluid.
Market Trends, Drivers, Restraints, and Opportunities
- Increasing awareness of STD and its advanced testing solutions due to education campaigns is expected to boost the market.
- Growing government initiatives especially in developing regions for the establishment of advanced healthcare infrastructure are anticipated to drive market growth during the forecast period.
- Rising number of technologically advanced products and devices for STD diagnostics that provide more precise testing results are anticipated to push the market expansion during the forecast period.
- Considering social taboo around the disease and preference for home treatment among patients in low and middle-income countries are key challenges that can hamper the market growth.
- Massive R&D activities from key players to improve diagnostic devices and its results is projected to create opportunities for the market expansion.
Scope of the Report
The report on the global STD diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
STD Diagnostics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Types (Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing, and Others), Locations of Testing (Laboratory Testing [Commercial/Private labs and Public Health Labs], and Point of Care Testing), Testing Devices (Laboratory Devices [Thermal Cyclers-PCR, Lateral Flow Readers, Flow Cytometers, Differential Light Scattering Machines, Absorbance Microplate Readers—Enzyme-Linked Immunosorbent Assay, and Others], and Point of Care Devices [Phone chips and Portable/bench top/rapid diagnostic kits]) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Roche Holdings AG; Abbott Laboratories; Becton Dickinson and Company; Hologic Inc.; Danaher Corporation; Affymetrix; bioMerieux; Cepheid Inc.; Alere Inc.; DiaSorin; and Orasure. |
Market Segment Insights
Chlamydia testing segment is projected to constitute a large market share
Based on types, the global STD diagnostics market is divided into chlamydia testing, syphilis testing, gonorrhea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing, chancroid testing, and others. The chlamydia segment is expected to account for a key share of the market during the forecast period owing to wide adoption of the type of testing. However, the syphilis testing segment is anticipated to exhibit a substantial CAGR during the forecast period due to the rising prevalence of syphilis infections worldwide. The diagnosis of STD caused by syphilis accounted for over 15% in 2020.
Point of care testing segment is expected to grow at a significant pace
On the basis of locations of testing, the market is bifurcated into laboratory testing and point of care testing. The laboratory segment is further divided into commercial/private labs and public health labs. The point of care testing segment is expected to account for a key share of the market during the forecast period owing to its rapid tests and results. Laboratory research, which is usually adopted in commercial/private labs and public health labs, is a time-consuming but more accurate process. Although point-of-care testing, which includes testing kits, is faster process, the results lack accuracy.
Point of care segment is anticipated to register at a substantial CAGR
Based on testing devices, the global STD diagnostics market is divided into laboratory devices and point of care devices. The laboratory devices segment is further divided into thermal cyclers—PCR, lateral flow readers, flow cytometers, differential light scattering machines, absorbance microplate readers—Enzyme-linked Immunosorbent assay (ELISA), and others. The point of care device segment is further bifurcated into phone chips (microfluidics + ICT), and portable/bench top/rapid diagnostic kits. The point of care segment is expected to account for a key share of the market during the forecast period. Phone chips (microfluidics and ICT) and portable/bench top/rapid diagnostic kits are included in the point of care testing devices category. Technology advancements of the point-of-care monitoring devices help to produce more accurate and reliable performance. The demand for portable point-of-care testing devices is estimated to exceed USD 26 billion during the forecast period.
Asia Pacific is anticipated to dominate the market
On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth can be attributed to wide prevalence of sexually transmitted infections and increasing acceptance of technologically advanced testing devices. Furthermore, the advent of novel POC testing concepts, public health laboratories offering sound STD testing utilities, and the availability of insurance coverage are driving factors for the regional market growth. On the other hand, North America dominated the STD diagnostic market owing to the prevalence of public healthcare insurance schemes and presence of large number of health-conscious population. The availability of FDA-approved advanced STD testing devices is acting as a key factor boosting the regional market expansion.
Segments
Segments Covered in the ReportThe global STD diagnostics market has been segmented on the basis of
Types
- Chlamydia Testing
- Syphilis Testing
- Gonorrhea Testing
- Herpes Simplex Virus Testing
- Human Papilloma Virus Testing
- Human Immunodeficiency Virus Testing
- Chancroid Testing
- Others
- Laboratory Testing
- Commercial/Private labs
- Public Health Labs
- Point of Care Testing
- Laboratory Devices
- Thermal Cyclers-PCR
- Lateral Flow Readers
- Flow Cytometers
- Differential Light Scattering Machines
- Absorbance Microplate Readers—Enzyme-Linked Immunosorbent Assay (Elisa)
- Others
- Point of Care Devices
- Phone chips (microfluidics + ICT)
- Portable/bench top/rapid diagnostic kits
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- Roche Holdings AG
- Abbott Laboratories
- Becton Dickinson and Company
- Hologic Inc.
- Danaher Corporation
- Affymetrix
- bioMerieux
- Cepheid Inc.
- Alere Inc.
- DiaSorin
- Orasure.
Competitive Landscape
Key players competing in the global STD diagnostics market include Roche Holdings AG; Abbott Laboratories; Becton Dickinson and Company; Hologic Inc.; Danaher Corporation; Affymetrix; bioMerieux; Cepheid Inc.; Alere Inc.; DiaSorin; and Orasure. These players are focusing on several market strategies especially collaboration and development of new product/technology to expand their market positions.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. STD Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. STD Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. STD Diagnostics Market - Supply Chain
4.5. Global STD Diagnostics Market Forecast
4.5.1. STD Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. STD Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. STD Diagnostics Market Absolute $ Opportunity
5. Global STD Diagnostics Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. STD Diagnostics Market Size and Volume Forecast by Types
5.3.1. Chlamydia Testing
5.3.2. Syphilis Testing
5.3.3. Gonorrhea Testing
5.3.4. Herpes Simplex Virus Testing
5.3.5. Human Papilloma Virus Testing
5.3.6. Human Immunodeficiency Virus Testing
5.3.7. Chancroid Testing
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global STD Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. STD Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global STD Diagnostics Demand Share Forecast, 2019-2026
7. North America STD Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America STD Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America STD Diagnostics Market Size and Volume Forecast by Types
7.4.1. Chlamydia Testing
7.4.2. Syphilis Testing
7.4.3. Gonorrhea Testing
7.4.4. Herpes Simplex Virus Testing
7.4.5. Human Papilloma Virus Testing
7.4.6. Human Immunodeficiency Virus Testing
7.4.7. Chancroid Testing
7.4.8. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America STD Diagnostics Demand Share Forecast, 2019-2026
8. Latin America STD Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America STD Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America STD Diagnostics Market Size and Volume Forecast by Types
8.4.1. Chlamydia Testing
8.4.2. Syphilis Testing
8.4.3. Gonorrhea Testing
8.4.4. Herpes Simplex Virus Testing
8.4.5. Human Papilloma Virus Testing
8.4.6. Human Immunodeficiency Virus Testing
8.4.7. Chancroid Testing
8.4.8. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America STD Diagnostics Demand Share Forecast, 2019-2026
9. Europe STD Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe STD Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe STD Diagnostics Market Size and Volume Forecast by Types
9.4.1. Chlamydia Testing
9.4.2. Syphilis Testing
9.4.3. Gonorrhea Testing
9.4.4. Herpes Simplex Virus Testing
9.4.5. Human Papilloma Virus Testing
9.4.6. Human Immunodeficiency Virus Testing
9.4.7. Chancroid Testing
9.4.8. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe STD Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific STD Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Types
10.4.1. Chlamydia Testing
10.4.2. Syphilis Testing
10.4.3. Gonorrhea Testing
10.4.4. Herpes Simplex Virus Testing
10.4.5. Human Papilloma Virus Testing
10.4.6. Human Immunodeficiency Virus Testing
10.4.7. Chancroid Testing
10.4.8. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific STD Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa STD Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Types
11.4.1. Chlamydia Testing
11.4.2. Syphilis Testing
11.4.3. Gonorrhea Testing
11.4.4. Herpes Simplex Virus Testing
11.4.5. Human Papilloma Virus Testing
11.4.6. Human Immunodeficiency Virus Testing
11.4.7. Chancroid Testing
11.4.8. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa STD Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global STD Diagnostics Market: Market Share Analysis
12.2. STD Diagnostics Distributors and Customers
12.3. STD Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Roche Holdings AG
12.4.2. Abbott Laboratories
12.4.3. Becton Dickinson and Company
12.4.4. Hologic Inc.
12.4.5. Danaher Corporation
12.4.6. Affymetrix
12.4.7. bioMerieux
12.4.8. Cepheid Inc.
12.4.9. Alere Inc.
12.4.10. DiaSorin
12.4.11. Orasure.
2. Assumptions and Acronyms Used
3. Research Methodology
4. STD Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. STD Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. STD Diagnostics Market - Supply Chain
4.5. Global STD Diagnostics Market Forecast
4.5.1. STD Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. STD Diagnostics Market Size (000’ Units) and Y-o-Y Growth
4.5.3. STD Diagnostics Market Absolute $ Opportunity
5. Global STD Diagnostics Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. STD Diagnostics Market Size and Volume Forecast by Types
5.3.1. Chlamydia Testing
5.3.2. Syphilis Testing
5.3.3. Gonorrhea Testing
5.3.4. Herpes Simplex Virus Testing
5.3.5. Human Papilloma Virus Testing
5.3.6. Human Immunodeficiency Virus Testing
5.3.7. Chancroid Testing
5.3.8. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global STD Diagnostics Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. STD Diagnostics Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global STD Diagnostics Demand Share Forecast, 2019-2026
7. North America STD Diagnostics Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America STD Diagnostics Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America STD Diagnostics Market Size and Volume Forecast by Types
7.4.1. Chlamydia Testing
7.4.2. Syphilis Testing
7.4.3. Gonorrhea Testing
7.4.4. Herpes Simplex Virus Testing
7.4.5. Human Papilloma Virus Testing
7.4.6. Human Immunodeficiency Virus Testing
7.4.7. Chancroid Testing
7.4.8. Others
7.5. Basis Point Share (BPS) Analysis by Types
7.6. Y-o-Y Growth Projections by Types
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America STD Diagnostics Demand Share Forecast, 2019-2026
8. Latin America STD Diagnostics Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America STD Diagnostics Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America STD Diagnostics Market Size and Volume Forecast by Types
8.4.1. Chlamydia Testing
8.4.2. Syphilis Testing
8.4.3. Gonorrhea Testing
8.4.4. Herpes Simplex Virus Testing
8.4.5. Human Papilloma Virus Testing
8.4.6. Human Immunodeficiency Virus Testing
8.4.7. Chancroid Testing
8.4.8. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America STD Diagnostics Demand Share Forecast, 2019-2026
9. Europe STD Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe STD Diagnostics Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe STD Diagnostics Market Size and Volume Forecast by Types
9.4.1. Chlamydia Testing
9.4.2. Syphilis Testing
9.4.3. Gonorrhea Testing
9.4.4. Herpes Simplex Virus Testing
9.4.5. Human Papilloma Virus Testing
9.4.6. Human Immunodeficiency Virus Testing
9.4.7. Chancroid Testing
9.4.8. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe STD Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific STD Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific STD Diagnostics Market Size and Volume Forecast by Types
10.4.1. Chlamydia Testing
10.4.2. Syphilis Testing
10.4.3. Gonorrhea Testing
10.4.4. Herpes Simplex Virus Testing
10.4.5. Human Papilloma Virus Testing
10.4.6. Human Immunodeficiency Virus Testing
10.4.7. Chancroid Testing
10.4.8. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific STD Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa STD Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa STD Diagnostics Market Size and Volume Forecast by Types
11.4.1. Chlamydia Testing
11.4.2. Syphilis Testing
11.4.3. Gonorrhea Testing
11.4.4. Herpes Simplex Virus Testing
11.4.5. Human Papilloma Virus Testing
11.4.6. Human Immunodeficiency Virus Testing
11.4.7. Chancroid Testing
11.4.8. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa STD Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global STD Diagnostics Market: Market Share Analysis
12.2. STD Diagnostics Distributors and Customers
12.3. STD Diagnostics Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Roche Holdings AG
12.4.2. Abbott Laboratories
12.4.3. Becton Dickinson and Company
12.4.4. Hologic Inc.
12.4.5. Danaher Corporation
12.4.6. Affymetrix
12.4.7. bioMerieux
12.4.8. Cepheid Inc.
12.4.9. Alere Inc.
12.4.10. DiaSorin
12.4.11. Orasure.
Our Clients
Related Reports
Some other reports from this category!
